Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome



Rating:

Share or cite this content

Citations should be made in the following way:
T. Heigl (Leuven, Belgium). Genetic variation in the STAT3 gene has an impact on survival after lung transplantation. 1559

Member's Comments

No comment yet.

Related content which might interest you: Up-regulation of γ-glutamyl-cysteine-synthetase gene expression after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 Genetic variations and lung function Source: Eur Respir J 2006; 28: Suppl. 50, 525s Year: 2006 Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Integrated mRNA and miRNA expression profiling of long-term survivors with normal allograft function after lung transplantation Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Gene expression markers to segregate lung transplant rejection phenotypes Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Polymorphisms in immunosuppression transporters affect outcome after lung transplantation. Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome Year: 2017 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 VEGF gene polymorphisms are associated with post-natal lung function development Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011 Overexpression of inhibitor of DNA-binding proteins and angiogenic markers have higher impact on survival of non small cell lung cancer patients Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 Neprilysin functional genetic polymorphism in NSCLC progression without PD-L1 expression Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 The use of mTOR inhibitors is associated with improved survival in lung transplant recipients Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020 Immunohistocemical expression of P53 and BCL-2 in pateints with lung cancer: correlation with survival time Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 Telomere length and genetic variant associations with interstitial lung disease progression and survival Source: Eur Respir J, 53 (4) 1801641; 10.1183/13993003.01641-2018 Year: 2019 The correlation between p53 gene mutation and the expression of tumor drug resistance genes in lung cancer and its clinical significance Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Genetic and environmental factors influencing lung growth and lung function Source: Eur Respir Mon; 2010: 47: 16–31 Year: 2010 Genetic polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021